Phase 2b, Open Label, Multisite, Randomized Crossover Study of DPP Versus 2PR
Phase 2b, Open Label, Multisite, Randomized Crossover Study of DPP Versus 2PR
Not yet recruiting · NCT07288190 · Registry updated 2026-02-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 2b, Open Label, Multisite, Randomized Crossover Study of DPP Versus 2PR | Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Not yet recruiting | Phase 2 | 2026-02-19 | NCT07288190 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| HIV Prevention Trials Network | 6 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 402 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Eswatini Prevention Center CRS | Mbabane | Eswatini | 2 |
| MU-JHU Research Collaboration (MUJHU CARE LTD) CRS | Kampala | Uganda | 3 |
| Spilhaus CRS | Harare | Zimbabwe | 2 |